Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Clinical trial NCT02231866 · COMPLETED
Trial details
- NCT number
- NCT02231866
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-27
- Primary completion
- 2017-04-05
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.